Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
CC transcript
|
|
CATALYST BIOSCIENCES, INC. (CBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/26/2021 |
4/A
| USMAN NASSIM (President & CEO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 140,000 options to buy
@ $5.89, valued at
$824.6k
|
|
| 04/26/2021 |
4/A
| Musil Clinton (CFO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 54,000 options to buy
@ $5.89, valued at
$318.1k
|
|
| 04/26/2021 |
4/A
| Levy Howard (Chief Medical Officer) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 25,000 options to buy
@ $5.89, valued at
$147.3k
|
|
| 02/14/2019 |
4/A
| Levy Howard (Chief Medical Officer) has filed a Form 4 on CATALYST BIOSCIENCES, INC. |
| 03/21/2018 |
4/A
| Flynn James E (10% Owner) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Sold 9,544 shares
@ $29.94, valued at
$285.7k
Sold 3,617 shares
@ $29.94, valued at
$108.3k
Sold 28,498 shares
@ $31.18, valued at
$888.6k
Sold 10,802 shares
@ $31.18, valued at
$336.8k
Sold 7,252 shares
@ $30, valued at
$217.6k
Sold 2,748 shares
@ $30, valued at
$82.4k
Sold 866 shares
@ $30, valued at
$26k
Sold 328 shares
@ $30, valued at
$9.8k
Sold 5,890 shares
@ $29.03, valued at
$171k
Sold 2,233 shares
@ $29.03, valued at
$64.8k
|
|
| 06/13/2016 |
4/A
| USMAN NASSIM (President and CEO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Acquired options to buy
@ $0 |
|
| 12/15/2015 |
4/A
| USMAN NASSIM (President & CEO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 153,572 options to buy
@ $4.4, valued at
$675.7k
|
|
| 12/15/2015 |
4/A
| SELICK HAROLD E (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 6,750 options to buy
@ $4.4, valued at
$29.7k
|
|
| 12/15/2015 |
4/A
| Richard John P (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC. |
| 12/15/2015 |
4/A
| Payne Fletcher (CFO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 28,572 options to buy
@ $4.4, valued at
$125.7k
|
|
| 12/15/2015 |
4/A
| Madison Edwin (Chief Scientific Officer) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 58,572 options to buy
@ $4.4, valued at
$257.7k
|
|
| 12/15/2015 |
4/A
| LAWLOR AUGUSTINE (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 6,750 options to buy
@ $4.4, valued at
$29.7k
|
|
| 12/15/2015 |
4/A
| HILL STEPHEN A (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC. |
| 12/15/2015 |
4/A
| DESOUZA ERROL B (Director) has filed a Form 4 on CATALYST BIOSCIENCES, INC. |
| 03/11/2013 |
4/A
| HILL STEPHEN A (President and CEO) has filed a Form 4 on TARGACEPT INC |
| 11/20/2012 |
4/A
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on TARGACEPT INC |
| 05/13/2011 |
4/A
| BURRILL STEVEN (Director) has filed a Form 4 on TARGACEPT INC |
| 03/02/2011 |
4/A
| Caldwell William S (SVP - Drug Discovery and Dev.) has filed a Form 4 on TARGACEPT INC |
| 06/23/2010 |
4/A
| BARRETT M JAMES (10% Owner) has filed a Form 4 on TARGACEPT INC|
Txns:
| Granted 7,500 options to buy
@ $22.76, valued at
$170.7k
|
|
| 01/05/2010 |
4/A
| Zorn Peter A (VP, Lg Affrs, GC and Secrtary) has filed a Form 4 on TARGACEPT INC |
| 12/30/2009 |
4/A
| Caldwell William S (VP - Drug Discovery and Dev.) has filed a Form 4 on TARGACEPT INC |
| 09/01/2009 |
4/A
| Caldwell William S (VP - Drug Discovery and Dev.) has filed a Form 4 on TARGACEPT INC |
|
|